Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 197 of 6351
-
Sound waves aimed at brain could ease severe OCD
Disease control Not yet recruitingThe goal of this clinical trial is to determine if ExAblate MR-guided Focused Ultrasound (MRgFUS) bilateral anterior capsulotomy can be used safely and effectively to relieve symptoms of moderate to severe obsessive compulsive disorder (OCD) in individuals who have not benefited …
Phase 1/2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could some breast cancer patients skip surgery? new trial investigates
Disease control Not yet recruitingThis clinical study aims to determine if skipping breast and axillary surgery could provide similar control of local and distant disease, with fewer complications and better quality of life, for triple-negative breast cancer patients in complete response after neoadjuvant chemo-i…
Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Three-Drug cocktail aims to beat aggressive leukemia
Disease control Not yet recruitingThis study is testing a new treatment combination called RAVEN, which includes revumenib, azacitidine, and venetoclax, in patients who are newly diagnosed with a specific type of acute myeloid leukemia (AML) called KMT2A- translocated AML. People with this type of AML often have…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a pill replace an IV for advanced breast cancer treatment?
Disease control Not yet recruitingThis study is a randomized controlled study.The primary objective is to evaluate the Progression-Free Survival(PFS) of Utidelone Capsule combined with Capecitabine compared with Utidelone Injection combined with Capecitabine in patients with HER-2 negative advanced breast cancer.
Phase 3 • Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a modified protein help immunotherapy fight a tough breast cancer?
Disease control Not yet recruitingThis study is a phase I/II open-label randomized clinical trial to examine whether administration of isunakinra (EBI-005), a modified recombinant IL1 receptor antagonist, can sensitize human TNBC to the PD1 inhibitor-pembrolizumab-based neoadjuvant chemotherapy (NAC/P) by changin…
Phase 1/2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a lower dose of radiation plus a targeted pill treat this lymphoma just as well?
Disease control Not yet recruitingMulti center, randomized, controlled, prospective clinical trial to explore the clinical efficacy and safety of low-dose radiotherapy combined with targeted therapy for localized MALT lymphoma.
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Exercise-Triggered heart valve leak targeted in new trial
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether mitral valve transcatheter edge-to-edge repair (TEER) in addition to guideline-directed medical therapy (GDMT) can improve clinical outcomes and symptoms in heart failure patients with non-severe secondary mitral regurgitation (…
Sponsor: Jena University Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Experimental shot aims to reverse HPV-Linked cervical precancer
Disease control Not yet recruitingThis is a randomized, double-blind, placebo controlled Phase 2 study to determine the efficacy and safety of NWRD09 administered by intramuscular (IM) injection in adult women with histologically confirmed cervical high grade squamous intraepithelial lesion (HSIL) (cervical intra…
Phase 2 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a new drug ease bulging eyes in thyroid disease?
Disease control Not yet recruitingThis is a multicenter, randomized, double-masked, placebo-controlled Phase 3 study to evaluate the efficacy, safety, immunogenicity, and population pharmacokinetic (PopPK) characteristics of KHN939 in Chinese patients with moderate-to-severe active thyroid eye disease (TED). Appr…
Phase 3 • Sponsor: Beijing Kanghong Biological Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a Triple-Drug cocktail before surgery curb prostate Cancer's return?
Disease control Not yet recruitingThe goal of this study is to evaluate the efficacy and safety of darolutamide combined with docetaxel and ADT compared to docetaxel combined with ADT in treating locally advanced prostate cancer patients scheduled for radical prostatectomy. The participant population includes adu…
Phase 2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a natural compound boost chemotherapy against endometrial cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Elemene Liposomes, combined with carboplatin and paclitaxel (TC) chemotherapy can improve prognosis in patients with advanced or recurrent endometrial cancer. The main question it aims to answer is: Does adding Elemene Liposomes to …
Phase 2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a new drug reduce bloodletting for polycythemia vera?
Disease control CancelledThis is a randomized, open-label, multicenter, two-arm study to assess the efficacy and safety of ropeginterferon alfa-2b for patients with PV. The entire study period is 60 weeks, including a main treatment phase (32 weeks), an extension treatment phase (24 weeks), and a safety …
Phase 4 • Sponsor: PharmaEssentia • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a Dual-Action drug combo outsmart advanced liver cancer?
Disease control Not yet recruitingThis clinical study aims to evaluate the efficacy and safety of Retlirafusp alfa Injection (SHR-1701) combined with apatinib in patients with advanced hepatocellular carcinoma (HCC) who have experienced disease progression after first-line targeted combined immunotherapy, and pro…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a robotic suit restore walking after stroke or spinal injury?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether the ZEPU AI9 lower limb exoskeleton robot is feasible, safe, and effective for people with walking difficulty caused by stroke, incomplete spinal cord injury, or orthopedic surgery. The main questions it aims to answer are: Is …
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can gut bacteria help rebuild immunity after stem cell transplants?
Disease control Not yet recruitingPatients who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) often experience slow and incomplete recovery of their immune system, particularly the part responsible for producing antibodies (humoral immunity). This can lead to increased risk of infections a…
Phase 1/2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new injection ease COPD and cut Flare-Ups?
Disease control Not yet recruitingThe main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), when compared with placebo. The study will last approximat…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can tiny electric acupuncture needles help women with low egg reserve conceive?
Disease control Not yet recruitingThe goal of this clinical trial is to examine the effect of ETN on live birth rate in patients with diminished ovarian reserve (DOR) undergoing in vitro fertilizitaion-embryo transfer (IVF-ET). Four hundred and six patients with DOR will be enrolled randomly divided into treatmen…
Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a smartphone app teach social cues to teens with autism?
Symptom relief Not yet recruitingThe purpose of this study is to evaluate the safety of NDTx-03 used together with treatment as usual (TAU) and to determine whether NDTx-03 plus TAU is more effective than TAU alone in improving social situation recognition and interaction in children and adolescents with autism …
Sponsor: Neudive Inc. • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Cutting radiation after surgery: a new hope for head and neck cancer patients?
Disease control Not yet recruitingThis was a phase II clinical study. Patients with histologically confirmed, resectable, locally advanced head and neck squamous cell carcinoma (HNSCC) without distant metastasis were enrolled. Enrolled patients received three cycles of neoadjuvant immunotherapy combined with chem…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Brain zaps in fast forward: a new hope for psychosis prevention?
Symptom relief Recruiting nowThe goal of this study is to learn whether an accelerated form of neuromodulation therapy is safe, feasible, and well tolerated in young people at clinical high risk for psychosis (CHR-P), and whether it is associated with changes in candidate biomarkers of treatment response. P…
Sponsor: Douglas Mental Health University Institute • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC